Delayed enrollment penalty for Medicare Part D comes with a sticker shock
In Mary Beth Franklin’s column, she answers a financial adviser’s question on how to avoid paying a delayed enrollment penalty
Read More
Part D/Prescription Drugs
Ketamine May Relieve Depression By Repairing Damaged Brain Circuits
(By Jon Hamilton for NPR) The anesthetic ketamine can relieve depression in hours and keep it at bay for a
Read MorePharma lobbyists flooded Maryland to block a drug-pricing bill. Opponents pushed back — and won
(By Lev Facher for STAT) ANNAPOLIS, Md. — The drug industry has long been seen as invincible in this small
Read MoreThe Blame Game: Everyone And No One Is Raising Insulin Prices
(By Rachel Bluth for Kaiser Health News) A casual observer of Wednesday’s House Energy and Commerce subcommittee hearing might think
Read MorePBMs sidestep the Senate’s tough questions — but lawmakers hint at legislation
(By Nicholas Florko for STAT) WASHINGTON — The much-maligned pharmacy middlemen escaped largely unscathed during a high-profile congressional hearing Tuesday
Read MoreOptumRx: 5 costly drugs coming this year
(By Alia Paavola for Becker’s Hospital Review) OptumRx released a list of five new and potentially expensive treatments coming to
Read MoreConsumers Rejected Drug Plan That Mirrors Trump Administration Proposal
(By Sydney Lupkin for Kaiser Health News) Unraveling how much of a prescription drug price gets swallowed by “middlemen” is
Read MoreDon’t make this Medicare mistake
According to TD Ameritrade, 44 percent people believe it will cover the bulk of their medical expenses in retirement; however,
Read MoreThis week, five pharmacy ‘middlemen’ head to Capitol Hill’s hot seat. Some of them have an easier defense than others
(By Nicholas Florko for STAT) WASHINGTON — President Trump has blasted them as “middlemen,” known for their “dishonest double dealing.”1
Read More3 drugmakers pay nearly $123M to settle kickback claims
(By Alia Paavola for Becker’s Hospital Review) Three drugmakers — Jazz Pharmaceuticals, Lundbeck and Alexion Pharmaceuticals — have agreed to pay $122.6
Read More